Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03959826 · ClinicalTrials.gov registry record · NA
Promoting Employment in Persons Living With HIV/AIDS
A NA study of HIV and Unemployment, sponsored by UConn Health.
- Active
- Registry status
- NA
- Development phase
- 144
- Enrollment target
- 1
- Study location
NCT03959826: Active NA study of HIV and Unemployment, sponsored by UConn Health.
NCT03959826 is a NA study of HIV and Unemployment that is active but no longer recruiting, run by UConn Health. The registered enrollment target is 144 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03959826, a NA study of HIV and Unemployment, is active but no longer recruiting, sponsored by UConn Health.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 144 participants
- Enrollment target
- 1
- Study location
Study Summary
Many persons living with HIV/AIDS (PLWHA) are unemployed, with estimates indicating rates as high as 60%. This study will examine the efficacy of reinforcing job-acquisition activities for improving employment outcomes in PLWHA who desire to return to the workforce in part- or full-time capacity. In total, this study will randomly assign 144 unemployed PLWHA to one of two interventions. All participants will receive usual unemployment services with an emphasis on specific issues related to HIV/AIDS, plus encouragement for completing activities geared toward employment readiness and acquisition. The enhanced intervention will involve that same treatment plus chances to win prizes for engaging in job-related activities each week. Participants will receive study treatments for 16 weeks and complete follow-up evaluations throughout 18 months. The hypothesis is that participants reinforced for completing job-related activities will transition to employment at higher and faster rates and work more often than those who are not reinforced for job-related activities.
Primary Outcome
self-report of job attainment: yes/no
Conditions Studied
Interventions
- BEHAVIORAL activity contracting
- BEHAVIORAL contingency management for activity completion
Study Locations (1)
Connecticut
- United Labor Agency - Middletown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2019-06-12 |
| Est. Completion | 2026-08-31 |
| Phase | NA |
What the registry record for NCT03959826 still lists
NCT03959826 is an interventional study that assigns participants to a tested intervention. The registered 144 participants enrollment target is mid-sized for trials with a published cap, below the 439-participant average among 303 other HIV trials with a reported enrollment target (67% lower).
The record links to 2 conditions, with HIV appearing as the primary indexed condition, and to 2 interventions - of which activity contracting is the first listed.
NCT03959826 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT03959826 about?
NCT03959826 is a clinical study titled "Promoting Employment in Persons Living With HIV/AIDS". Many persons living with HIV/AIDS (PLWHA) are unemployed, with estimates indicating rates as high as 60%. This study will examine the efficacy of reinforcing job-acquisition activities for improving employment outcomes in PLWHA who desire to return to the workforce in part- or full-time capacity. In...
What is the current status of trial NCT03959826?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 144 participants. The study started on 2019-06-12. Estimated completion is 2026-08-31.
What conditions does trial NCT03959826 study?
This clinical trial studies the following conditions: HIV, Unemployment.
What interventions are being tested in trial NCT03959826?
The interventions under investigation include: activity contracting (BEHAVIORAL), contingency management for activity completion (BEHAVIORAL).
Who is sponsoring clinical trial NCT03959826?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03959826 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03959826's enrollment target sits among peer trials
144 135th of 303 higher than 169 of 303 other HIV trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
RECRUITING · NA
-
Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01861106 · 144 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
- NCT03482245 · 144 participants · NA
The Role of Circadian Clock Proteins in Innate and Adaptive Immunity
- NCT03504683 · 144 participants · NA
MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes
- NCT03905603 · 144 participants · Early Phase 1
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI